We are live on
!
Find out more
O
OrbiMed Portfolio holdings
AUM
$4.59B
1-Year Est. Return
125.28%
This Fund
S&P 500
This Quarter
Est. Return
+37.76%
1 Year Est. Return
+125.28%
3 Year Est. Return
+334.72%
5 Year Est. Return
+344.07%
10 Year Est. Return
+2,748.76%
AUM
$4.89B
AUM Growth
+$717M
(+17%)
Cap. Flow
-$266M
Cap. Flow
% of AUM
-5.43%
Top 10 Holdings %
Top 10 Hldgs %
40.48%
Holding
126
New
22
Increased
22
Reduced
35
Closed
16
Top Buys
| 1 |
Pfizer
PFE
|
+$41.7M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$37.3M |
| 3 |
Elevance Health
ELV
|
+$33.5M |
| 4 |
HELP
Cybin Inc
HELP
|
+$24.7M |
| 5 |
Bruker
BRKR
|
+$23.5M |
Top Sells
| 1 |
TERN
Terns Pharmaceuticals
TERN
|
+$125M |
| 2 |
RNAM
Avidity Biosciences
RNAM
|
+$65.8M |
| 3 |
EXAS
Exact Sciences
EXAS
|
+$51.6M |
| 4 |
Axsome Therapeutics
AXSM
|
+$38.9M |
| 5 |
SI-BONE Inc
SIBN
|
+$38M |
Sector Composition
| 1 | Healthcare | 99.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALMS
76
Alumis Inc
ALMS
$3.63B
| $10.8M | 0.22% |
1,102,730
-823,693
| -43% | -$5.75M |
|
|
BIOA
77
BioAge Labs
BIOA
$1B
| $10.5M | 0.21% |
790,901
| – | – |
|
|
FOLD
78
DELISTED
Amicus Therapeutics
FOLD
| $10.4M | 0.21% |
729,900
-915,500
| -56% | -$8.99M |
|
|
WHWK
79
Whitehawk Therapeutics
WHWK
$191M
| $10.1M | 0.21% |
4,166,000
| – | – |
|
80
Adicet Bio
ACET
$81.3M
| $8.66M | 0.18% |
1,027,944
+312,498
| +44% | +$3.45M |
|
|
RPTX
81
DELISTED
Repare Therapeutics
RPTX
| $8.64M | 0.18% |
3,322,488
| – | – |
|
82
Celcuity
CELC
$4.54B
| $8.54M | 0.17% |
85,664
+1,644
| +2% | +$135K |
|
|
JBIO
83
Jade Biosciences
JBIO
$1.3B
| $8.2M | 0.17% |
531,163
| – | – |
|
84
Kiniksa Pharmaceuticals
KNSA
$4.73B
| $7.72M | 0.16% |
+187,199
| New | +$7.51M |
|
85
Q32 Bio
QTTB
$276M
| $7.48M | 0.15% |
2,252,987
| – | – |
|
86
PMV Pharmaceuticals
PMVP
$75.2M
| $6.22M | 0.13% |
4,975,291
-1,000,000
| -17% | -$1.34M |
|
|
KALV
87
DELISTED
KalVista Pharmaceuticals
KALV
| $6.18M | 0.13% |
+382,400
| New | +$5.06M |
|
88
Pharvaris
PHVS
$2.47B
| $5.7M | 0.12% |
+205,400
| New | +$4.95M |
|
89
InspireMD
NSPR
$33.5M
| $5.58M | 0.11% |
3,133,405
+1,000,000
| +47% | +$2.08M |
|
90
Insmed
INSM
$23.8B
| $4.42M | 0.09% |
25,400
+11,941
| +89% | +$2.18M |
|
91
Palisade Bio
PALI
$351M
| $4.4M | 0.09% |
+1,871,420
| New | +$3.6M |
|
|
BCAX
92
Bicara Therapeutics
BCAX
$1.84B
| $3.52M | 0.07% |
+209,100
| New | +$3.57M |
|
93
Cullinan Oncology
CGEM
$1.09B
| $2.79M | 0.06% |
270,006
-1,653,849
| -86% | -$14.9M |
|
94
C4 Therapeutics
CCCC
$416M
| $2.68M | 0.05% |
1,404,902
-3,830,244
| -73% | -$9.07M |
|
|
IMA
95
ImageneBio Inc
IMA
$67.8M
| $2.61M | 0.05% |
378,556
| – | – |
|
96
Alto Neuroscience
ANRO
$982M
| $2.23M | 0.05% |
125,000
-125,000
| -50% | -$1.57M |
|
97
Revolution Medicines
RVMD
$39.3B
| $2.06M | 0.04% |
+25,900
| New | +$1.7M |
|
98
VistaGen Therapeutics
VTGN
$10M
| $2.03M | 0.04% |
3,060,000
| – | – |
|
99
Ocular Therapeutix
OCUL
$2.17B
| $1.91M | 0.04% |
+157,300
| New | +$1.91M |
|
100
Protagonist Therapeutics
PTGX
$8.9B
| $1.9M | 0.04% |
+21,700
| New | +$1.78M |
|
Similar funds
CGI
LNWTC
SCM
AG
SCM
SV
ANTB
ECM